We are Scaled Microbiomics
A biotechnology company that is pioneering microbiome immunotherapy for disease interception
We are Scaled Microbiomics
A biotechnology company that is pioneering microbiome immunotherapy for disease interception
Who We Are
As scientists and clinicians, we have dedicated our careers to an integrated approach to responding to disease and conditions driving adverse human health. With our understanding of the Microbiome, we have developed patented technology to disrupt the disease cascade of the myriad of diseases and health conditions strongly associated with the Human Microbiome.
Scaled Microbiomics has discovered solutions that can be rapidly and cost-effectively developed and deployed to address human health needs – providing diagnostics, prophylactics, and treatments to combat targeted conditions with our patented platform technology.
Mission
To protect and change society by leading the way in disease interception based on modulating microbiome signaling pathways and providing innovative therapeutics across a broad spectrum of disease states.
Value Proposition
Intercepting microbiome-driven disease and supporting wellness with targeted, passive immunotherapeutics that modulate microbiome-host signaling pathways through rational systems biology-based drug design.
Who We Are
As scientists and clinicians, we have dedicated our careers to an integrated approach to responding to disease and conditions driving adverse human health. With our understanding of the Microbiome, we have developed patented technology to disrupt the disease cascade of the myriad of diseases and health conditions strongly associated with the Human Microbiome.
Scaled Microbiomics has discovered solutions that can be rapidly and cost-effectively developed and deployed to address human health needs – providing diagnostics, prophylactics, and treatments to combat targeted conditions with our patented platform technology.
Mission
To protect and change society by leading the way in disease interception based on modulating microbiome signaling pathways and providing innovative therapeutics across a broad spectrum of disease states.
Value Proposition
Intercepting microbiome-driven disease and supporting wellness with targeted, passive immunotherapeutics that modulate microbiome-host signaling pathways through rational systems biology-based drug design.
Our Model
Scaled Microbiomics’ Worldview and Strategy
SMB has precision technology to target specific pathobionts which cause and contribute to the disease cascade.
- Microbiomes are being recognized as “new organs” interacting with and providing essential function to the whole organism.
- As with other organs, the cells constituting a microbiome engage in intra- and inter-cellular communications as well as in signaling cascades with other tissues and organs
Our Model
Scaled Microbiomics’ Worldview and Strategy
SMB has precision technology to target specific pathobionts which cause and contribute to the disease cascade.
- Microbiomes are being recognized as “new organs” interacting with and providing essential function to the whole organism.
- As with other organs, the cells constituting a microbiome engage in intra- and inter-cellular communications as well as in signaling cascades with other tissues and organs
Our Model
Scaled Microbiomics’ Worldview and Strategy
SMB has precision technology to target specific pathobionts which cause and contribute to the disease cascade.
- Microbiomes are being recognized as “new organs” interacting with and providing essential function to the whole organism.
- As with other organs, the cells constituting a microbiome engage in intra- and inter-cellular communications as well as in signaling cascades with other tissues and organs
